Alabama Therapeutics CRS [clinicaltrials_resource:1f62951caa980784d48f1b5ac328dfb4]
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3 [clinicaltrials:NCT00000625]Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [clinicaltrials:NCT00000626]A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3 [clinicaltrials:NCT00000754]A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients [clinicaltrials:NCT00000768]A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection [clinicaltrials:NCT00000793]A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides [clinicaltrials:NCT00000802]A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy [clinicaltrials:NCT00000803]A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy [clinicaltrials:NCT00000820]A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients [clinicaltrials:NCT00000863]A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone [clinicaltrials:NCT00000870]Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [clinicaltrials:NCT00000903]A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [clinicaltrials:NCT00000916]Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 [clinicaltrials:NCT00000923]The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [clinicaltrials:NCT00001030]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS [clinicaltrials:NCT00001059]Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS [clinicaltrials:NCT00001061]A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole [clinicaltrials:NCT00001065]The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs [clinicaltrials:NCT00001067]A Study of Disease Progression and Anti-HIV Treatments [clinicaltrials:NCT00001068]Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors [clinicaltrials:NCT00001073]A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients [clinicaltrials:NCT00001085]Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [clinicaltrials:NCT00001133]Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV [clinicaltrials:NCT00006145]Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination [clinicaltrials:NCT00006291]Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV [clinicaltrials:NCT00011011]Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [clinicaltrials:NCT00013520]Telephone Support to Improve Adherence to Anti-HIV Medications [clinicaltrials:NCT00988442]
location [clinicaltrials_vocabulary:location]
Alabama Therapeutics CRS [clinicaltrials_resource:1f62951caa980784d48f1b5ac328dfb4]
Bio2RDF identifier
1f62951caa980784d48f1b5ac328dfb4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1f62951caa980784d48f1b5ac328dfb4
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:1f62951caa980784d48f1b5ac328dfb4
title
Alabama Therapeutics CRS
@en
type
label
Alabama Therapeutics CRS [clinicaltrials_resource:1f62951caa980784d48f1b5ac328dfb4]
@en